LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Life‐threatening pregnancy‐associated atypical haemolytic uraemic syndrome and its response to eculizumab

Photo by kellysikkema from unsplash

Pregnancy‐associated atypical haemolytic uraemic syndrome (P‐aHUS) is a rare, potentially lethal condition that can complicate pregnancy in up to 1 in 25 000 cases. Without prompt diagnosis and initiation of… Click to show full abstract

Pregnancy‐associated atypical haemolytic uraemic syndrome (P‐aHUS) is a rare, potentially lethal condition that can complicate pregnancy in up to 1 in 25 000 cases. Without prompt diagnosis and initiation of appropriate treatment, this condition can lead to disastrous consequences for both mother and child. Given the broad spectrum of conditions that can present similarly in the peripartum period, it is often difficult to establish the correct diagnosis in a timely manner. Recently, the terminal complement cascade inhibitor eculizumab has been used with considerable success in non‐pregnancy HUS; however, its use in P‐aHUS is limited to isolated case reports. Here, we present a case of fulminant P‐aHUS in the postpartum period that was successfully treated with eculizumab resulting in significant recovery of renal function.

Keywords: pregnancy; uraemic syndrome; atypical haemolytic; haemolytic uraemic; associated atypical; pregnancy associated

Journal Title: Nephrology
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.